Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan · Delayed Price · Currency is TWD 23.95
-0.75 (-3.04%)
Sep 8, 2026, 1:30 PM CST
Formosa Pharmaceuticals Market Cap
Formosa Pharmaceuticals has a market cap or net worth of 3.73 billion as of September 8, 2026. Its market cap has decreased by -21.21% in one year.
Market Cap
3.73B
Enterprise Value
2.54B
Revenue
52.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.95
ChartMarket Cap Chart
Since October 7, 2021, Formosa Pharmaceuticals's market cap has decreased from 5.53B to 3.73B, a decrease of -32.62%. That is a compound annual growth rate of -7.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 3.73B | -6.44% |
| Dec 31, 2025 | 3.99B | -29.51% |
| Dec 31, 2024 | 5.65B | -15.62% |
| Dec 29, 2023 | 6.70B | 13.17% |
| Dec 30, 2022 | 5.92B | 74.66% |
| Dec 30, 2021 | 3.39B | -38.75% |
| Oct 7, 2021 | 5.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmosa Biopharm | 4.26B |
| Sinew Pharma | 3.69B |
| BioGend Therapeutics | 3.53B |
| SYN-TECH Chem. & Pharm. | 3.36B |
| BRIM Biotechnology | 3.35B |
| OBI Pharma | 3.28B |
| Shine-On BioMedical | 3.20B |
| Apex Biotechnology | 3.17B |